Sign in

CIK 0001517022 · Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208756903
Phone
617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. 8-K Event Executive or director change
  3. 4 Open-market sale SVP, Chief Accounting Officer sold 5,833 shares at $2.29 ($13,335)
  4. CT ORDER Other Confidential Order
  5. 8-K/A Event Executive or director change
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 8-K Event Executive or director change
  11. 4 Derivatives Options or other derivatives
  12. 8-K Event Other events
  13. 8-K Event Regulation FD disclosure
  14. 4 Open-market sale SVP, Chief Medical Officer sold 1,042 shares at $2.83 ($2,949)
  15. 8-K Event Other events
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. SC 13G/A Stake Amended Statement of Ownership
  20. 4 Open-market sale Director sold 4,567 shares at $3.32 ($15,163)

Page 17 of 45 · 886 filings